Nuveen Asset Management’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.48M | Sell |
87,097
-10,221
| -11% | -$173K | ﹤0.01% | 2515 |
|
|
2024
Q3 | $2.26M | Buy |
97,318
+7,675
| +9% | +$178K | ﹤0.01% | 2351 |
|
|
2024
Q2 | $2.18M | Sell |
89,643
-34,222
| -28% | -$833K | ﹤0.01% | 2342 |
|
|
2024
Q1 | $4.18M | Sell |
123,865
-70,817
| -36% | -$2.39M | ﹤0.01% | 2081 |
|
|
2023
Q4 | $6.14M | Buy |
194,682
+336
| +0.2% | +$10.6K | ﹤0.01% | 1864 |
|
|
2023
Q3 | $4.97M | Buy |
194,346
+6,014
| +3% | +$154K | ﹤0.01% | 1871 |
|
|
2023
Q2 | $5.4M | Buy |
188,332
+40,168
| +27% | +$1.15M | ﹤0.01% | 1870 |
|
|
2023
Q1 | $3.55M | Buy |
148,164
+79,617
| +116% | +$1.91M | ﹤0.01% | 2075 |
|
|
2022
Q4 | $1.16M | Sell |
68,547
-41,541
| -38% | -$705K | ﹤0.01% | 2629 |
|
|
2022
Q3 | $1.63M | Buy |
110,088
+1,482
| +1% | +$22K | ﹤0.01% | 2506 |
|
|
2022
Q2 | $1.71M | Buy |
108,606
+17,148
| +19% | +$270K | ﹤0.01% | 2513 |
|
|
2022
Q1 | $2.24M | Sell |
91,458
-3,467
| -4% | -$84.8K | ﹤0.01% | 2453 |
|
|
2021
Q4 | $3.51M | Buy |
94,925
+4,292
| +5% | +$159K | ﹤0.01% | 2294 |
|
|
2021
Q3 | $4.94M | Sell |
90,633
-37,539
| -29% | -$2.04M | ﹤0.01% | 2218 |
|
|
2021
Q2 | $4.34M | Buy |
128,172
+49,906
| +64% | +$1.69M | ﹤0.01% | 2323 |
|
|
2021
Q1 | $3.23M | Sell |
78,266
-17,947
| -19% | -$741K | ﹤0.01% | 2382 |
|
|
2020
Q4 | $4.17M | Buy |
96,213
+23,936
| +33% | +$1.04M | ﹤0.01% | 2166 |
|
|
2020
Q3 | $3.1M | Buy |
72,277
+9,745
| +16% | +$418K | ﹤0.01% | 2160 |
|
|
2020
Q2 | $2.92M | Buy |
+62,532
| New | +$2.92M | ﹤0.01% | 2171 |
|